Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationMultiple MyelomaBone MarrowTransplantation, HomologousAntineoplastic Combined Chemotherapy ProtocolsMelphalanBone Marrow TransplantationTransplantation ConditioningCombined Modality TherapyBone Marrow CellsTreatment OutcomeRemission InductionStem CellsSalvage TherapyDisease-Free SurvivalCyclophosphamideEtoposideHodgkin DiseaseLymphoma, Non-HodgkinBone Marrow PurgingRecurrenceCytarabineGraft vs Host DiseaseMyeloablative AgonistsCarmustineHematopoietic Stem Cell MobilizationHematopoietic Stem CellsSurvival RateThiotepaWhole-Body IrradiationVincristineHematologic NeoplasmsSurvival AnalysisLymphoma, Mantle-CellRetrospective StudiesBusulfanAmyloidosisBone and BonesDoxorubicinGraft SurvivalPrognosisAntigens, CD34DexamethasoneBoronic AcidsPyrazinesFollow-Up StudiesAntibodies, Monoclonal, Murine-DerivedLymphoma, FollicularLymphoma, T-Cell, PeripheralAntineoplastic Agents, AlkylatingTime FactorsGranulocyte Colony-Stimulating FactorAutograftsAntineoplastic AgentsMesenchymal Stem Cell TransplantationLiver TransplantationThalidomideIfosfamideTransplantation ChimeraLymphomaInduction ChemotherapyLeukapheresisPrednisoneLeukemia, Myeloid, AcutePodophyllotoxinNeoplasm, ResidualTissue DonorsLymphoma, Large B-Cell, DiffuseMyelodysplastic SyndromesHematopoiesisCell DifferentiationMaintenance ChemotherapyCord Blood Stem Cell TransplantationCell TransplantationLymphoma, B-CellKidney TransplantationBone Marrow DiseasesEmbryonic Stem CellsMitoxantroneLeukemiaAntibodies, MonoclonalIdarubicinHistocompatibility TestingEnteropathy-Associated T-Cell LymphomaLeukemia, Plasma CellProspective StudiesLeukemia, MyeloidNeoplasms, Second PrimaryImmunosuppressive AgentsCisplatinAdult Stem CellsInfusions, SpinalBlood Component RemovalCells, CulturedCarboplatinMesenchymal Stromal CellsT-Lymphocytes